NCT00116441
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,958 public trials
2,018 recruiting studies
Immunoproliferative Disorders trial results
NCT00165347
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00086216
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT00558220
- Conditions
- Diffuse Large B-Cell Lymphoma., Follicular Lymphoma Grade III, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- University Hospital Brno-Bohunice Brno, Czechia
- Hospital Chomutov Chomutov, Czechia
- Hospital České Budějovice České Budějovice, Czechia
- University Hospital Hradec Králové Hradec Králové, Czechia
NCT00556127
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Az. Ospedaliera SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
- Ospedale Regionale, Divisione di Oncologia, Aosta, Italy
- Azienda Ospedaliera Ospedale Policlinico Consorziale Bari, Italy
- Osp. degli Infermi Biella, Italy
Completed
Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children
NCT00552825
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloblastic Leukemia, Hematologic Diseases, +17 more
- Locations
-
- Sheba Medical CenterPediatric pulmonary unit, Pulmonary function laboratory Ramat Gan, Israel
NCT00536393
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Clinique Victor Hugo Le Mans, France
NCT00536458
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Regional university hospital Besançon, France
Completed
Phase III Study Treatment of CLL B and C
NCT00535912
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
Not specified
NCT00256191
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +9 more
- Locations
-
- Rocky Mountain Cancer Center Denver, Colorado, United States